Abiopharma

🔍 Arnold Ken E. (Executive)

Company: AVNET INC (AVT)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 21,452 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 82,951.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 7,908 shares of Employee Stock Option (Right to Buy) at $44.12 per share (Derivative)
  Date: 2026-08-20 | Code: H | Expires: 2029-02-17 | shares_owned_after: 7,908.00 | Footnotes: F3
• Holds 12,404 shares of Employee Stock Option (Right to Buy) at $39.72 per share (Derivative)
  Date: 2026-08-20 | Code: H | Expires: 2029-08-12 | shares_owned_after: 12,404.00 | Footnotes: F3
• Holds 33,604 shares of Employee Stock Option (Right to Buy) at $29.85 per share (Derivative)
  Date: 2026-08-20 | Code: H | Expires: 2030-11-15 | shares_owned_after: 33,604.00 | Footnotes: F4

Footnotes:

• F1: Consists of restricted stock units and performance stock units earned under long-term incentive plans.
• F2: Includes 30,189 unvested restricted stock units and 12,766 unvested performance stock units.
• F3: The Option vests in four equal annual installments beginning on the first anniversary of the date of grant.
• F4: The Option vests in four equal annual installments beginning on the first anniversary of the date of grant.